CoChat
Sign Up
Cited by 48

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Determinants of bone marrow adiposity: The modulation of peroxisome proliferator-activated receptor-γ2 activity as a central mechanism

Sadie-Van Gijsen, H., Hough, F.S., Ferris, W.F.·2013·Bone
DOI 10.1016/j.bone.2013.06.016
Open this paper in CoChat — free account

Abstract

Although the presence of adipocytes in the bone marrow is a normal physiological phenomenon, the role of these cells in bone homeostasis and during pathological states has not yet been fully delineated. As osteoblasts and adipocytes originate from a common progenitor, with an inverse relationship existing between osteoblastogenesis and adipogenesis, bone marrow adiposity often negatively correlates with osteoblast number and bone mineral density. Bone adiposity can be affected by several physiological and pathophysiological factors, with abnormal, elevated marrow fat resulting in a pathological state. This review focuses on the regulation of bone adiposity by physiological factors, including aging, mechanical loading and growth factor expression, as well as the pathophysiological factors, including diseases such as anorexia nervosa and dyslipidemia, and pharmacological agents such as thiazolidinediones and statins. Although these factors regulate bone marrow adiposity via a plethora of different intracellular signaling pathways, these diverse pathways often converge on the modulation of the expression and/or activity of the pro-adipogenic transcription factor peroxisome proliferator-activated receptor (PPAR)-γ2, suggesting that any factor that affects PPAR-γ2 may have an impact on the fat content of bone.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.bone.2013.06.016

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 9 references

Research works printed but not linked: 233

  1. Nuttall, 2004, Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications, Curr Opin Pharmacol, 4, 290, 10.1016/j.coph.2004.03.002 · DOI
  2. Gimble, 2006, Playing with bone and fat, J Cell Biochem, 98, 251, 10.1002/jcb.20777 · DOI
  3. Justesen, 2001, Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis, Biogerontology, 2, 165, 10.1023/A:1011513223894 · DOI
  4. Verma, 2002, Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis, J Clin Pathol, 55, 693, 10.1136/jcp.55.9.693 · DOI
  5. Shen, 2007, MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women, Osteoporos Int, 18, 641, 10.1007/s00198-006-0285-9 · DOI
  6. Di Iorgi, 2008, Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults, J Clin Endocrinol Metab, 93, 2281, 10.1210/jc.2007-2691 · DOI
  7. Di Iorgi, 2010, Bone acquisition in healthy young females is reciprocally related to marrow adiposity, J Clin Endocrinol Metab, 95, 2977, 10.1210/jc.2009-2336 · DOI
  8. Wren, 2011, Bone marrow fat is inversely correlated to cortical bone in young and old subjects, J Clin Endocrinol Metab, 96, 782, 10.1210/jc.2010-1922 · DOI
  9. Bredella, 2011, Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women, Obesity (Silver Spring), 19, 49, 10.1038/oby.2010.106 · DOI
  10. Shen, 2012, Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African–American and Caucasian participants: the CARDIA study, J Clin Endocrinol Metab, 97, 1337, 10.1210/jc.2011-2605 · DOI
  11. Song, 2004, Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow, FASEB J, 18, 980, 10.1096/fj.03-1100fje · DOI
  12. Moore, 1990, Red and yellow marrow in the femur: age-related changes in appearance at MR imaging, Radiology, 175, 219, 10.1148/radiology.175.1.2315484 · DOI
  13. Kugel, 2001, Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow, J Magn Reson Imaging, 13, 263, 10.1002/1522-2586(200102)13:2<263::AID-JMRI1038>3.0.CO;2-M · DOI
  14. Liney, 2007, Age, gender, and skeletal variation in bone marrow composition: a preliminary study at 3.0 Tesla, J Magn Reson Imaging, 26, 787, 10.1002/jmri.21072 · DOI
  15. De Bisschop, 1993, Fat fraction of lumbar bone marrow using in vivo proton nuclear magnetic resonance spectroscopy, Bone, 14, 133, 10.1016/8756-3282(93)90239-7 · DOI
  16. Griffith, 2012, Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects, J Magn Reson Imaging, 36, 225, 10.1002/jmri.23619 · DOI
  17. Rozman, 1989, Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: a stereological study, Exp Hematol, 17, 34
  18. Ecklund, 2010, Bone marrow changes in adolescent girls with anorexia nervosa, J Bone Miner Res, 25, 298, 10.1359/jbmr.090805 · DOI
  19. Devlin, 2010, Caloric restriction leads to high marrow adiposity and low bone mass in growing mice, J Bone Miner Res, 25, 2078, 10.1002/jbmr.82 · DOI
  20. Wajchenberg, 1995, Estimation of body fat and lean tissue distribution by dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease, J Clin Endocrinol Metab, 80, 2791
  21. Björntorp, 1996, The regulation of adipose tissue distribution in humans, Int J Obes Relat Metab Disord, 20, 291
  22. Vande Berg, 1999, Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging, Arthritis Rheum, 42, 1405, 10.1002/1529-0131(199907)42:7<1405::AID-ANR14>3.0.CO;2-W · DOI
  23. Baum, 2012, Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?, J Magn Reson Imaging, 35, 117, 10.1002/jmri.22757 · DOI
  24. Geer, 2012, Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI, J Clin Endocrinol Metab, 97, 1702, 10.1210/jc.2011-3123 · DOI
  25. Gimble, 1996, The function of adipocytes in the bone marrow stroma: an update, Bone, 19, 421, 10.1016/S8756-3282(96)00258-X · DOI
  26. Rosen, 2006, Mechanisms of disease: is osteoporosis the obesity of bone?, Nat Clin Pract Rheumatol, 2, 35, 10.1038/ncprheum0070 · DOI
  27. Lecka-Czernik, 2012, Marrow fat metabolism is linked to the systemic energy metabolism, Bone, 50, 534, 10.1016/j.bone.2011.06.032 · DOI
  28. Kawai, 2010, PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis, Nat Rev Endocrinol, 6, 629, 10.1038/nrendo.2010.155 · DOI
  29. Krings, 2012, Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes, Bone, 50, 546, 10.1016/j.bone.2011.06.016 · DOI
  30. Tran, 1981, Effects of catecholamines on free fatty acid release from bone marrow adipose tissue, J Lipid Res, 22, 1271, 10.1016/S0022-2275(20)37320-X · DOI
  31. Lecka-Czernik, 2010, PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism, Curr Osteoporos Rep, 8, 84, 10.1007/s11914-010-0016-1 · DOI
  32. Sadie-Van Gijsen, 2013, The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity, Cell Mol Life Sci, 70, 2331, 10.1007/s00018-012-1211-2 · DOI
  33. Elbaz, 2010, Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro, J Cell Mol Med, 14, 982, 10.1111/j.1582-4934.2009.00751.x · DOI
  34. Hozumi, 2009, Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation, Biochem Biophys Res Commun, 382, 780, 10.1016/j.bbrc.2009.03.111 · DOI
  35. Uckan, 2009, Adipocyte differentiation defect in mesenchymal stromal cell of patients with malignant infantile osteopetrosis, Cytotherapy, 11, 392, 10.1080/14653240802582083 · DOI
  36. Nishikawa, 1993, Changes in hematopoiesis-supporting ability of C3H10T1/2 mouse embryo fibroblasts during differentiation, Blood, 81, 1184, 10.1182/blood.V81.5.1184.1184 · DOI
  37. Belaid-Choucair, 2008, Human bone marrow adipocytes block granulopoiesis through neurolipin-1-induced granulocyte colony-stimulating factor inhibition, Stem Cells, 26, 1556, 10.1634/stemcells.2008-0068 · DOI
  38. Yan, 2007, The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance, Diabetes, 56, 2533, 10.2337/db07-0007 · DOI
  39. Miharada, 2008, Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells, J Cell Physiol, 215, 526, 10.1002/jcp.21334 · DOI
  40. Zhang, 1995, Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoeitic progenitors in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro, Blood, 86, 2930, 10.1182/blood.V86.8.2930.2930 · DOI
  41. Yokota, 2000, Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages, Blood, 96, 1723, 10.1182/blood.V96.5.1723 · DOI
  42. Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
  43. Hodgkinson, 2009, Adult stem cells in tissue engineering, Expert Rev Med Devices, 6, 621, 10.1586/erd.09.48 · DOI
  44. Lecka-Czernik, 2006, Resolving the two “bony” faces of PPAR-gamma, PPAR Res, 2006, 27489, 10.1155/PPAR/2006/27489 · DOI
  45. Hasegawa, 2008, The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations, BMC Dev Biol, 8, 71, 10.1186/1471-213X-8-71 · DOI
  46. Fretz, 2010, Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse, Endocrinology, 151, 1611, 10.1210/en.2009-0987 · DOI
  47. Huang, 2010, Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1, Bone, 46, 1138, 10.1016/j.bone.2009.12.020 · DOI
  48. Duque, 2013, Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice, J Bone Miner Res, 28, 639, 10.1002/jbmr.1782 · DOI
  49. Zhu, 1995, Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms, Proc Natl Acad Sci U S A, 92, 7921, 10.1073/pnas.92.17.7921 · DOI
  50. Fajas, 1997, The organization, promoter analysis, and expression of the human PPARgamma gene, J Biol Chem, 272, 18779, 10.1074/jbc.272.30.18779 · DOI
  51. Tontonoz, 1994, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer, Genes Dev, 8, 1224, 10.1101/gad.8.10.1224 · DOI
  52. Shockley, 2009, PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells, J Cell Biochem, 106, 232, 10.1002/jcb.21994 · DOI
  53. Akune, 2004, PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors, J Clin Invest, 113, 846, 10.1172/JCI200419900 · DOI
  54. Tontonoz, 1994, Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor, Cell, 79, 1147, 10.1016/0092-8674(94)90006-X · DOI
  55. Zhu, 2010, Regulation of multilineage gene expression and apoptosis during in vitro expansion of human bone marrow stromal cells with different cell culture media, Cells Tissues Organs, 192, 211, 10.1159/000313417 · DOI
  56. Yu, 2012, PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells, Int J Biochem Cell Biol, 44, 377, 10.1016/j.biocel.2011.11.013 · DOI
  57. Sadie-Van Gijsen, 2010, Depot-specific differences in the insulin response of adipose-derived stromal cells, Mol Cell Endocrinol, 328, 22, 10.1016/j.mce.2010.06.009 · DOI
  58. Berger, 2000, A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus, Mol Cell Endocrinol, 162, 57, 10.1016/S0303-7207(00)00211-2 · DOI
  59. Burgermeister, 2007, Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma, Mol Cell Biol, 27, 803, 10.1128/MCB.00601-06 · DOI
  60. Tontonoz, 1994, Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha, Nucleic Acids Res, 22, 5628, 10.1093/nar/22.25.5628 · DOI
  61. Piters, 2008, Wnt signaling: a win for bone, Arch Biochem Biophys, 473, 112, 10.1016/j.abb.2008.03.006 · DOI
  62. Westendorf, 2004, Wnt signaling in osteoblasts and bone diseases, Gene, 341, 19, 10.1016/j.gene.2004.06.044 · DOI
  63. Bennett, 2005, Regulation of osteoblastogenesis and bone mass by Wnt10b, Proc Natl Acad Sci U S A, 102, 3324, 10.1073/pnas.0408742102 · DOI
  64. Jackson, 2005, Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells, Bone, 36, 585, 10.1016/j.bone.2005.01.007 · DOI
  65. Moldes, 2003, Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis, Biochem J, 376, 607, 10.1042/bj20030426 · DOI
  66. Floyd, 2012, Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ, Biochim Biophys Acta, 1822, 1090, 10.1016/j.bbadis.2012.03.014 · DOI
  67. Takada, 2007, A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation, Nat Cell Biol, 9, 1273, 10.1038/ncb1647 · DOI
  68. Hong, 2006, TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation, Cell Cycle, 5, 176, 10.4161/cc.5.2.2362 · DOI
  69. Cheng, 2003, MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors, J Biol Chem, 278, 45969, 10.1074/jbc.M306972200 · DOI
  70. Lecka-Czernik, 1999, Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2, J Cell Biochem, 74, 357, 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7 · DOI
  71. Manolagas, 2000, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, Endocr Rev, 21, 115
  72. Duque, 2008, Bone and fat connection in aging bone, Curr Opin Rheumatol, 20, 429, 10.1097/BOR.0b013e3283025e9c · DOI
  73. Griffith, 2005, Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy, Radiology, 236, 945, 10.1148/radiol.2363041425 · DOI
  74. Syed, 2008, Effects of estrogen therapy on bone marrow adipocytes in post-menopausal osteoporotic women, Osteoporos Int, 19, 1323, 10.1007/s00198-008-0574-6 · DOI
  75. Kajkenova, 1997, Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia, J Bone Miner Res, 12, 1772, 10.1359/jbmr.1997.12.11.1772 · DOI
  76. D'Ippolito, 1999, Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow, J Bone Miner Res, 14, 1115, 10.1359/jbmr.1999.14.7.1115 · DOI
  77. Mueller, 2001, Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges, J Cell Biochem, 82, 583, 10.1002/jcb.1174 · DOI
  78. Moerman, 2004, Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-ß/BMP signaling pathway, Aging Cell, 3, 379, 10.1111/j.1474-9728.2004.00127.x · DOI
  79. Justesen, 2002, Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures, Calcif Tissue Int, 71, 36, 10.1007/s00223-001-2059-x · DOI
  80. Finkel, 2000, Oxidants, oxidative stress and the biology of aging, Nature, 408, 239, 10.1038/35041687 · DOI · Paper page
  81. Mody, 2001, Oxidative stress modulates osteoblastic differentiation of vascular and bone cells, Free Radic Biol Med, 31, 509, 10.1016/S0891-5849(01)00610-4 · DOI
  82. Parhami, 1999, Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells, J Bone Miner Res, 14, 2067, 10.1359/jbmr.1999.14.12.2067 · DOI
  83. Huang, 1999, Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase, Nature, 400, 378, 10.1038/22572 · DOI
  84. Almeida, 2009, Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-γ expression, and diminished pro-osteogenic Wnt signalling in the skeleton, J Biol Chem, 284, 27438, 10.1074/jbc.M109.023572 · DOI
  85. Nishikawa, 2010, Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation, J Clin Invest, 120, 3455, 10.1172/JCI42528 · DOI
  86. Serria, 2003, Regulation and differential expression of the c-maf gene in differentiating cultured cells, Biochem Biophys Res Commun, 310, 318, 10.1016/j.bbrc.2003.08.144 · DOI
  87. Almeida, 2007, Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids, J Biol Chem, 282, 27285, 10.1074/jbc.M702810200 · DOI
  88. Shouhed, 2005, Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells, J Cell Biochem, 95, 1276, 10.1002/jcb.20497 · DOI
  89. Kim, 2007, 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism, J Bone Miner Res, 22, 1711, 10.1359/jbmr.070710 · DOI
  90. Kim, 2010, Hedgehod signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress, J Cell Biochem, 111, 1199, 10.1002/jcb.22846 · DOI
  91. Jemai, 2008, Hypolipidimic and antioxidant activities of oleuropein and its hydrolysis derivative-rich extracts from Chemlali olive leaves, Chem Biol Interact, 176, 88, 10.1016/j.cbi.2008.08.014 · DOI
  92. Kasdallah-Grissa, 2008, Dietary virgin olive oil protects against lipid peroxidation and improves antioxidant status in the liver of rats chronically exposed to ethanol, Nutr Res, 28, 472, 10.1016/j.nutres.2008.03.014 · DOI
  93. Santiago-Mora, 2011, Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect of differentiation in stem cells derived from bone marrow, Osteoporos Int, 22, 675, 10.1007/s00198-010-1270-x · DOI
  94. Bonnefont-Rousselot, 2000, Consequences of the diabetic status on the oxidant/antioxidant balance, Diabetes Metab, 26, 163
  95. Botolin, 2005, Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice, Endocrinology, 146, 3622, 10.1210/en.2004-1677 · DOI
  96. Botolin, 2006, Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss, J Cell Physiol, 209, 967, 10.1002/jcp.20804 · DOI
  97. Coe, 2011, Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity, J Cell Biochem, 112, 2403, 10.1002/jcb.23163 · DOI
  98. Slade, 2012, Human bone marrow adiposity is linked with serum lipids not T1-diabetes, J Diabet Complicat, 26, 1, 10.1016/j.jdiacomp.2011.11.001 · DOI
  99. Zayzafoon, 2004, Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis, Endocrinology, 145, 2421, 10.1210/en.2003-1156 · DOI
  100. Ahdjoudj, 2002, Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma, J Bone Miner Res, 17, 668, 10.1359/jbmr.2002.17.4.668 · DOI
  101. Wronski, 1981, Skeletal alterations in rats during space flight, Adv Space Res, 1, 135, 10.1016/0273-1177(81)90254-4 · DOI
  102. Trudel, 2009, Bone marrow fat accumulation after 60days of bed rest persisted 1year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study, J Appl Physiol, 107, 540, 10.1152/japplphysiol.91530.2008 · DOI
  103. Minaire, 1984, Marrow changes in paraplegic patients, Calcif Tissue Int, 36, 338, 10.1007/BF02405340 · DOI
  104. Luu, 2009, Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity, J Bone Miner Res, 24, 50, 10.1359/jbmr.080817 · DOI
  105. Yuki, 2010, Upregulation of osteogenic factors induced by high-impact jumping suppresses adipogenesis in marrow but not adipogenic transcription factors in rat tibiae, Eur J Appl Physiol, 109, 641, 10.1007/s00421-010-1383-0 · DOI
  106. David, 2007, Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis, Endocrinology, 148, 2553, 10.1210/en.2006-1704 · DOI
  107. Chen, 2011, Treadmill training prevents bone loss by inhibition of PPARγ expression but not promoting of Runx2 expression in ovariectomized rats, Eur J Appl Physiol, 111, 1759, 10.1007/s00421-010-1820-0 · DOI
  108. Colleran, 2000, Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling, J Appl Physiol, 89, 1046, 10.1152/jappl.2000.89.3.1046 · DOI
  109. Ren, 2006, Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions, Biochem Biophys Res Commun, 347, 12, 10.1016/j.bbrc.2006.05.169 · DOI
  110. Ontiveros, 2004, Hypoxia suppresses runx2 independent of modeled microgravity, J Cell Physiol, 200, 169, 10.1002/jcp.20054 · DOI
  111. Brookoff, 1982, Adipocyte development and the loss of erythropoietic capacity in the bone marrow of mice after sustained hypertransfusion, Blood, 60, 1337, 10.1182/blood.V60.6.1337.1337 · DOI
  112. McManus, 1984, Busulfan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies, Blood, 64, 1036, 10.1182/blood.V64.5.1036.1036 · DOI
  113. Burkhardt, 1987, Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study, Bone, 8, 157, 10.1016/8756-3282(87)90015-9 · DOI
  114. Lipetz, 1997, Anemia and serum protein deficiencies in patients with traumatic spinal cord injury, J Spinal Cord Med, 20, 335, 10.1080/10790268.1997.11719485 · DOI
  115. Islam, 1988, Do bone marrow fat cells or their precursors have a pathogenic role in idiopathic aplastic anemia?, Med Hypotheses, 25, 209, 10.1016/0306-9877(88)90032-1 · DOI
  116. Payne, 2007, Anemia of immobility: caused by adipocyte accumulation in bone marrow, Med Hypotheses, 69, 778, 10.1016/j.mehy.2007.01.077 · DOI
  117. Xu, 2009, Downregulation of GATA-2 and overexpression of adipogenic gene-PPARγ in mesenchymal stem cells from patients with aplastic anemia, Exp Hematol, 37, 1393, 10.1016/j.exphem.2009.09.005 · DOI
  118. Tong, 2003, GATA transcription factors and fat cell formation, Drug News Perspect, 16, 585, 10.1358/dnp.2003.16.9.829340 · DOI
  119. Abella, 2002, Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings, Am J Clin Pathol, 118, 582, 10.1309/2Y7X-YDXK-006B-XLT2 · DOI
  120. Bredella, 2009, Increased bone marrow fat in anorexia nervosa, J Clin Endocrinol Metab, 94, 2129, 10.1210/jc.2008-2532 · DOI
  121. Ecklund, 2010, Bone marrow changes in adolescent girls with anorexia nervosa, J Bone Miner Res, 25, 298, 10.1359/jbmr.090805 · DOI
  122. Devlin, 2010, Caloric restriction leads to high marrow adiposity and low bone mass in growing mice, J Bone Miner Res, 25, 2078, 10.1002/jbmr.82 · DOI
  123. Lawson, 2008, Endocrine abnormalities in anorexia nervosa, Nat Clin Pract, 4, 407, 10.1038/ncpendmet0872 · DOI
  124. Misra, 2010, Neuroendocrine consequences of anorexia nervosa in adolescents, Endocr Dev, 17, 197, 10.1159/000262540 · DOI
  125. Fazeli, 2010, Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa, J Clin Endocrinol Metab, 95, 407, 10.1210/jc.2009-1152 · DOI
  126. Hamrick, 2007, Injections of leptin into rat ventromeidal hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow, Cell Tissue Res, 327, 133, 10.1007/s00441-006-0312-3 · DOI
  127. Gevers, 2002, Bone marrow adipocytes: a neglected target tissue for growth hormone, Endocrinology, 143, 4065, 10.1210/en.2002-220428 · DOI
  128. Rosen, 2004, Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program, Bone, 35, 1046, 10.1016/j.bone.2004.07.008 · DOI
  129. Devlin, 2011, Why does starvation make bones fat?, Am J Hum Biol, 23, 577, 10.1002/ajhb.21202 · DOI
  130. Guo, 2011, A role for suppressed bone formation favouring catch-up fat in the pathophysiology of catch-up growth after food restriction, Eur J Nutr, 50, 645, 10.1007/s00394-011-0174-7 · DOI
  131. Maes, 2010, Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels, Dev Cell, 19, 329, 10.1016/j.devcel.2010.07.010 · DOI · Paper page
  132. Wilson, 2010, Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells, BMC Genomics, 11, 229, 10.1186/1471-2164-11-229 · DOI · Paper page
  133. Liu, 2012, Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation, J Clin Invest, 122, 3101, 10.1172/JCI61209 · DOI
  134. Brunner, 1991, Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan, J Cell Biol, 114, 1275, 10.1083/jcb.114.6.1275 · DOI
  135. Sabbieti, 1999, Prostaglandins regulate the expression of fibroblast growth factor-2 in bone, Endocrinology, 140, 434, 10.1210/endo.140.1.6442 · DOI
  136. Xiao, 2010, Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells, Bone, 47, 360, 10.1016/j.bone.2010.05.021 · DOI
  137. Itoh, 2004, Evolution of the Fgf and Fgfr gene families, Trends Genet, 20, 563, 10.1016/j.tig.2004.08.007 · DOI
  138. Reitman, 2007, FGF21: a missing link in the biology of fasting, Cell Metab, 5, 405, 10.1016/j.cmet.2007.05.010 · DOI
  139. Wei, 2012, Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ, Proc Natl Acad Sci U S A, 109, 3143, 10.1073/pnas.1200797109 · DOI · Paper page
  140. Yamashita, 2004, The transactivating function of peroxisome proliferator-activated receptor γ is negatively regulated by SUMO conjugation in the amino-terminal domain, Genes Cells, 9, 1017, 10.1111/j.1365-2443.2004.00786.x · DOI
  141. Chau, 2010, Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway, Proc Natl Acad Sci U S A, 107, 12553, 10.1073/pnas.1006962107 · DOI
  142. Hsu, 2006, Relation of body composition, fat mass and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women, Am J Clin Nutr, 83, 146, 10.1093/ajcn/83.1.146 · DOI · Paper page
  143. Orozco, 2004, Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women, Eur J Epidemiol, 19, 1105, 10.1007/s10654-004-1706-8 · DOI
  144. Cui, 2005, Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea, Osteoporos Int, 16, 1975, 10.1007/s00198-005-1977-2 · DOI
  145. Corwin, 2006, Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III, J Nutr, 136, 159, 10.1093/jn/136.1.159 · DOI
  146. Michaëlsson, 1995, Diet, bone mass, and osteocalcin: a cross-sectional study, Calcif Tissue Int, 57, 86, 10.1007/BF00298425 · DOI
  147. Cooper, 1996, Dietary protein intake and bone mass in women, Calcif Tissue Int, 58, 320, 10.1007/BF02509379 · DOI
  148. Parhami, 1999, Atherogenic diet and minimally oxidized low density lipoprotein inhibit ostegenic and promote adipogenic differentiation of marrow stromal cells, J Bone Miner Res, 14, 2067, 10.1359/jbmr.1999.14.12.2067 · DOI
  149. Chen, 2010, Obesity reduces bone density associated with activation of PPARγ and suppression of Wnt/ß-catenin in rapidly growing male rats, PLoS One, 5, e13704, 10.1371/journal.pone.0013704 · DOI
  150. Chen, 2012, Inhibition of fetal bone development through epigenetic downregulation of HoxA10 in obese rats fed high-fat diet, FASEB, 26, 1131, 10.1096/fj.11-197822 · DOI
  151. Badilla, 2000, Characterization of cocoa butter extracted from hybrid cultivars of Theobroma cacao L, Arch Latinoam Nutr, 50, 200
  152. Beadle, 1965, Composition of corn oil, J Am Oil Chem Soc, 42, 90, 10.1007/BF02545036 · DOI
  153. Rahman, 2011, t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity, J Cell Physiol, 226, 2406, 10.1002/jcp.22578 · DOI
  154. Halade, 2011, Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice, J Nutr Biochem, 22, 459, 10.1016/j.jnutbio.2010.03.015 · DOI
  155. Casado-Diaz, 2013, The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis, Osteoporos Int, 24, 1647, 10.1007/s00198-012-2138-z · DOI
  156. Granlund, 2003, Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator, J Lipid Res, 44, 1441, 10.1194/jlr.M300120-JLR200 · DOI
  157. Platt, 2009, Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid, J Nutr Biochem, 20, 956, 10.1016/j.jnutbio.2008.08.008 · DOI
  158. Kim, 2013, trans-10,cis-12 Conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator-activated receptor-γ-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells, J Nutr Biochem, 24, 672, 10.1016/j.jnutbio.2012.03.017 · DOI
  159. Song, 2003, Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells, Biochem Biophys Res Commun, 308, 458, 10.1016/S0006-291X(03)01408-6 · DOI
  160. Li, 2003, Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures, Bone, 33, 652, 10.1016/S8756-3282(03)00239-4 · DOI
  161. Liu, 2009, The effect of simvastatin on the differentiation of marrow stromal cells from aging rats, Pharmazie, 64, 43
  162. Slater, 1988, Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative, Drugs, 36, 72, 10.2165/00003495-198800363-00016 · DOI
  163. Endo, 1977, Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, Eur J Biochem, 77, 31, 10.1111/j.1432-1033.1977.tb11637.x · DOI
  164. Ye, 2007, Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2, Prostaglandins Other Lipid Mediat, 84, 43, 10.1016/j.prostaglandins.2007.04.001 · DOI
  165. Yano, 2007, Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages, Circ Res, 100, 1442, 10.1161/01.RES.0000268411.49545.9c · DOI
  166. Nicholson, 2007, Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression, Br J Pharmacol, 151, 807, 10.1038/sj.bjp.0707250 · DOI
  167. Majima, 2007, Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia, Endocr J, 54, 145, 10.1507/endocrj.K06-127 · DOI
  168. Bone, 2007, Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial, J Clin Endocrinol Metab, 92, 4671, 10.1210/jc.2006-1909 · DOI
  169. Yue, 2010, Statins and bone health in post-menopausal women: a systematic review of randomized controlled trials, Menopause, 17, 1071, 10.1097/gme.0b013e3181d3e036 · DOI
  170. Lupattelli, 2004, Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women, Metabolism, 53, 744, 10.1016/j.metabol.2004.01.010 · DOI
  171. Edwards, 2000, Oral statins and increased bone-mineral density in postmenopausal women, Lancet, 355, 2218, 10.1016/S0140-6736(00)02408-9 · DOI
  172. Uzzan, 2007, Effects of statins on bone mineral density: a meta-analysis of clinical studies, Bone, 40, 1581, 10.1016/j.bone.2007.02.019 · DOI
  173. Mundy, 1999, Stimulation of bone formation in vitro and in rodents by statins, Science, 286, 1946, 10.1126/science.286.5446.1946 · DOI
  174. Maritz, 2001, Effects of statins on bone mineral density and bone histomorphometry in rodents, Arterioscler Thromb Vasc Biol, 21, 1636, 10.1161/hq1001.097781 · DOI
  175. Chuengsamarn, 2010, Effects of statins vs non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidaemia, Bone, 46, 1011, 10.1016/j.bone.2009.12.023 · DOI
  176. Weivoda, 2012, Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation, Bone, 50, 467, 10.1016/j.bone.2011.09.056 · DOI
  177. Benayahu, 2000, Hormonal changes affect the bone and bone marrow cells in a rat model, J Cell Biochem, 79, 407, 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8 · DOI · Paper page
  178. Elbaz, 2009, Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice, Biogerontology, 10, 747, 10.1007/s10522-009-9221-7 · DOI
  179. Somjen, 2001, The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow, J Endocrinol Invest, 34, 106, 10.1007/BF03347039 · DOI
  180. Okazaki, 2002, Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta, Endocrinology, 143, 2349, 10.1210/endo.143.6.8854 · DOI
  181. Porcu, 2005, The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension, Trends Pharmacol Sci, 26, 94, 10.1016/j.tips.2004.12.009 · DOI
  182. Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583 · DOI
  183. Backesjö, 2006, Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells, J Bone Miner Res, 21, 993, 10.1359/jbmr.060415 · DOI
  184. Tseng, 2011, Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis, J Bone Miner Res, 26, 2552, 10.1002/jbmr.460 · DOI
  185. Goldberg, 1995, A global survey of trans-resveratrol concentrations in commercial wines, Am J Enol Vitic, 46, 1589-165, 10.5344/ajev.1995.46.2.159 · DOI
  186. Su, 2007, Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol, J Biol Chem, 282, 19385, 10.1074/jbc.M702452200 · DOI
  187. Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 · DOI · Paper page
  188. Heim, 2004, The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells, Endocrinology, 145, 848, 10.1210/en.2003-1014 · DOI
  189. Lagari, 2010, Phytoestrogens and bone health, Curr Opin Endocrinol Diab Obes, 17, 546, 10.1097/MED.0b013e32833f4867 · DOI
  190. Shalhoub, 1992, Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes, J Cell Biochem, 50, 425, 10.1002/jcb.240500411 · DOI
  191. Canalis, 2007, Glucocorticoid-induced osteoporosis: pathophysiology and therapy, Osteoporos Int, 18, 1319, 10.1007/s00198-007-0394-0 · DOI
  192. Rosen, 2009, Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis, Am J Med, 122, 409, 10.1016/j.amjmed.2008.11.027 · DOI
  193. Zhou, 2008, Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling, J Biol Chem, 283, 1936, 10.1074/jbc.M702687200 · DOI
  194. Zhou, 2009, Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice, Development, 136, 427, 10.1242/dev.027706 · DOI
  195. Ohnaka, 2005, Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts, Biochem Biophys Res Commun, 329, 177, 10.1016/j.bbrc.2005.01.117 · DOI
  196. Pereira, 2002, Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression, Bone, 30, 685, 10.1016/S8756-3282(02)00687-7 · DOI
  197. Idris, 2010, Cannabinoids and bone: friend or foe?, Calcif Tissue Int, 87, 285, 10.1007/s00223-010-9378-8 · DOI
  198. Pertwee, 2002, Cannabinoid receptors and their ligands, Prostaglandins Leukot Essent Fatty Acids, 66, 101, 10.1054/plef.2001.0341 · DOI
  199. Ofek, 2006, Peripheral cannabinoid receptor, CB2, regulates bone mass, Proc Natl Acad Sci U S A, 103, 696, 10.1073/pnas.0504187103 · DOI
  200. Idris, 2009, Cannabinoid receptor type I protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells, Cell Metab, 10, 139, 10.1016/j.cmet.2009.07.006 · DOI

200 of 233 shown

Cited by

Sorted by citations

See all 48

Metadata

Authors
Sadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F.
Venue
Bone
Publisher
Elsevier BV
Published
2013-10
Volume
56
Issue
2
Pages
255-265
ISSN
8756-3282
DOI
10.1016/j.bone.2013.06.016
Cited by
48
References
9
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Research Foundation of South Africa
  • Medical Research Council (MRC) of South Africa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review